Publication | Open Access
Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease
116
Citations
14
References
2013
Year
Compared with metformin, exenatide is better to control blood glucose, reduces body weight and improves hepatic enzymes, attenuating NAFLD in patients with T2DM concomitant with NAFLD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1